Nicolas Bronchart, Executive Vice President of R&D, commented, "Dr.Mehta has pulled together a world-class team of clinicians and medical physicists that will deliver his vision of establishing Miami Cancer Institute as a center for some of the most advanced cancer radiation therapy options. Our work together at Miami Cancer Institute will not only benefit the patients of South Florida but will potentially impact how cancer is treated throughout the world."
Dr. Mehta stated: "Because Baptist Hospital and Miami Cancer Institute have committed major resources to the enhancement of comprehensive cancer care and research in the region, we have been very successful in attracting the best and most highly qualified individuals from around the world to participate in this exciting program which can be best characterized as having an optimal balance between the highest quality cancer care and cutting-edge research. This major research and educational grant further enhances this critical mission of ours."
Ad Statistics
Times Displayed: 21862
Times Visited: 433 Stay up to date with the latest training to fix, troubleshoot, and maintain your critical care devices. GE HealthCare offers multiple training formats to empower teams and expand knowledge, saving you time and money
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA's proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world. IBA is listed on the Pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
More information can be found at: www.iba-worldwide.com
About Miami Cancer Institute
Baptist Hospital's Miami Cancer Institute is a major destination cancer center known for its leading clinical care, exceptional patient experience, advanced clinical research and state-of-the-art technology – including the first proton therapy center in South Florida with extensive reach to the Caribbean, Latin America and beyond. To accelerate its mission of hope, caring and innovation, Miami Cancer Institute has joined the Memorial Sloan Kettering Cancer Alliance, a dynamic partnership that will enable cancer patients to access potential breakthrough therapies in South Florida. For more information, visit MiamiCancerInstitute.com.
Miami Cancer Institute is part of Baptist Health South Florida, the largest healthcare organization in the region, with ten hospitals (Baptist Hospital, Baptist Children's Hospital, Doctors Hospital, Homestead Hospital, Mariners Hospital, South Miami Hospital, West Kendall Baptist Hospital, Fishermen's Community Hospital, Bethesda Hospital East and Bethesda Hospital West), nearly 50 outpatient and urgent care facilities, Baptist Health Medical Group, Baptist Health Quality Network and internationally renowned centers of excellence. With this extensive network, Miami Cancer Institute and Baptist Hospital are uniquely positioned to serve a large portion of South Florida's population with the most sophisticated cancer treatment options. The not-forprofit, faith-based Baptist Health has approximately 16,000 employees and 2,300 affiliated physicians. Baptist Health South Florida has been recognized as one of the 100 Best Companies to Work For in America and as one of the World's Most Ethical Companies. For more information, visit BaptistHealth.net and connect with us on Facebook at Facebook.com/baptistHealthSF and on Twitter and Instagram @BaptistHealthSF.
Back to HCB News
